Roivant Sciences (ROIV) Interest Coverage Ratio (2020 - 2025)
Roivant Sciences (ROIV) posted Interest Coverage Ratio of 4639.89 for Q3 2025, down 199.64% on a QoQ basis from 1548.49 in Q2 2025, and down 156050.86% year-over-year from N/an in Q3 2024.
Roivant Sciences (ROIV) Interest Coverage Ratio (2020 - 2025) Analysis & Trends
Roivant Sciences' Interest Coverage Ratio history runs 6 years deep, the most recent figure standing at 4639.89 for Q3 2025.
- Quarterly Interest Coverage Ratio fell 156050.86% year-over-year to 4639.89 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 25018.14 (down 64469.86% YoY) and the FY2026 annual result came in at 0.32, up 77.46% from the prior year.
- Interest Coverage Ratio was 4639.89 for Q3 2025 at Roivant Sciences, down from 1548.49 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 185.76 in Q4 2023 and bottomed at 4639.89 in Q3 2025.
- A 5-year average of 462.14 and a median of 26.86 in 2022 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio jumped 482.76% — and 2025, when it sank 156050.86%.
- Roivant Sciences' Interest Coverage Ratio stood at 194.9 in 2021, then soared by 75.1% to 48.53 in 2022, then soared by 482.76% to 185.76 in 2023, then plunged by 103.42% to 6.35 in 2024, then sank by 73019.14% to 4639.89 in 2025.
- Business Quant data shows ROIV's Interest Coverage Ratio at 4639.89 in Q3 2025, 1548.49 in Q2 2025, and 6.35 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -4,639.89 |
| Jun 30, 2025 | -1,548.49 |
| Dec 31, 2024 | -6.35 |
| Sep 30, 2024 | -2.97 |
| Jun 30, 2024 | -1.26 |
| Dec 31, 2023 | 185.76 |
| Sep 30, 2023 | -23.00 |
| Jun 30, 2023 | -28.93 |
| Dec 31, 2022 | -48.53 |
| Sep 30, 2022 | -24.80 |
| Jun 30, 2022 | -23.80 |
| Dec 31, 2021 | -194.90 |
| Sep 30, 2021 | -51.34 |
| Jun 30, 2021 | -61.44 |
| Dec 31, 2020 | -351.52 |
| Sep 30, 2020 | -257.47 |
| Jun 30, 2020 | -144.69 |